TY  - JOUR
T1  - Emerging therapies of hemangioblastomas
AU  - Sanghadia, Chaitanya
AU  - Martinez, Melanie E.
AU  - McNulty, Marisa
AU  - Russ, Eric
AU  - Woolridge, Maxwell
AU  - Cao, Dat Thanh
AU  - Micunovic, Marko
AU  - Roberts, Jeffery
AU  - Perez, Juan
AU  - Lucke-Wold, Brandon
Y1  - 2023///
JO  - Exploration of Neuroscience
VL  - 2
IS  - 6
SP  - 318
EP  - 330
DO  - 10.37349/en.2023.00031
UR  - https://www.explorationpub.com/Journals/en/Article/100631
AB  - Hemangioblastoma are benign, vascularized cranial tumors caused by autosomal dominant inherited von Hippel-Lindau disease or can appear sporadically. This review will investigate current and emerging treatments for cerebral tumors. It will focus on the current and, more importantly, developing hemangioblastoma treatments. Surgical resectioning and radiotherapy are effective treatment options for cerebral tumors, whereas chemotherapies are not commonly used due to their limited ability to penetrate the blood-brain barrier. Recent chemotherapies have shown promise, but further research is needed to determine the efficacy as a treatment for hemangioblastomas. New advances in brachytherapy and immunotherapy are considered promising treatment options for hemangioblastoma. This review aims to offer valuable insights into the latest developments in hemangioblastoma treatments.
ER  -